China SXT Pharmaceuticals, Inc.
Q2 2024 13F Holders
Symbol
SXTC
CUSIP
G2161P140
Type
Equity
Class
SHS NEW
Num filers
8
Total reported value, excl. options
$79.9 k
Compare 2024 Q2 to
2024 Q4
2024 Q3
2024 Q1
2023 Q4
Manager
Report Date
Value ($000)
Shares
Option Type